Literature DB >> 20890480

Bones beyond 70--insights into osteoporosis management in the elderly.

Charles Inderjeeth1, Anabela Smeath.   

Abstract

BACKGROUND: Bone mineral density is presently the only reliable diagnostic test for osteoporosis.
METHODS: Using quantitative questionnaires, general practitioners prospectively evaluated their own investigation and treatment of osteoporosis in patients aged more than 70 years.
RESULTS: Data are available for 114 GPs; 2850 patients (cycle 1) and 1710 patients (cycle 2). Of the 25.4% with a prior fracture, bone mineral density had been assessed in 55.5% (cycle 1) and 67.0% (cycle 2; p<0.05). Among patients with no documented prior fracture, bone mineral density had been assessed in 39.4% (cycle 1) and 56.9% (cycle 2; p<0.05). DISCUSSION: Bone mineral density is subsidised for all patients aged more than 70 years, yet GPs are more likely to request bone mineral density tests only among those who already have a fracture. General practitioner education on the role of bone mineral density testing among all patients aged 70 years or more is important as it influences initiation of appropriate osteoporosis treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20890480

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

1.  Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study.

Authors:  A Modi; P R Ebeling; M S Lee; Y K Min; A Mithal; X Yang; S Baidya; S Sen; S Sajjan
Journal:  Bone Rep       Date:  2017-09-20

2.  Secondary prevention of osteoporosis in non-neck of femur fragility fractures: is it value for money? A retrospective, prospective and cross-sectional cohort study.

Authors:  Tamer Mettyas; Clare Carpenter
Journal:  J Orthop Surg Res       Date:  2013-12-01       Impact factor: 2.359

3.  Comparison of three tools for predicting primary osteoporosis in an elderly male population in Beijing: a cross-sectional study.

Authors:  XiaoDong Zhang; JiSheng Lin; Qi Fei; Yong Yang; Hao Wu; Yongjin Li; Xiuquan Yang
Journal:  Clin Interv Aging       Date:  2018-02-02       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.